Registry of antithrombotic therapy in patients with atrial fibrillation under replacement with bioprosthetic valve. (Prospective observational study)

Not Applicable

• Conditions: Patients with atrial fibrillation after replacement with bioprosthetic valve.

• Registration Number: JPRN-UMIN000034485
• Lead Sponsor: ational Cerebral and Cardiovascular Center DAIICHI SANKYO CO., LTD.

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-10-15
• Study Completion: 2020-10-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 928

Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients currently participating or scheduled to participate in intervention studies 2) Patients who are judged by research director as valvular atrial fibrillation 3) Any patients who are deemed inappropriate by research director or co-investigators

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Development of stroke/systemic embolism and major bleeding during the observation period

Secondary Outcome Measures

Name	Time	Method
the rates of the following events: stroke; systemic embolism; ischemic stroke; hemorrhagic stroke; intracranial hemorrhage; cardiovascular events (including myocardial infarction, stroke, systemic embolism, and death from bleeding); and bleeding events (including clinically significant bleeding and minor bleeding)